Hemoglobin variants and hemoglobin A1c analysis: Problem solved?

Clinical Chemistry

Volumn 49, Issue 8, 2003, Pages 1245-1247

  Sacks, David B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN A1C;

CAPILLARY ELECTROPHORESIS; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLYCATION; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MEDICAL SOCIETY; STANDARDIZATION;

AMINO ACID SUBSTITUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; DIABETES MELLITUS, TYPE 1; FALSE NEGATIVE REACTIONS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; IMMUNOASSAY; OXYGEN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0041866808     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.8.1245     Document Type: Editorial

References (18)

1. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Gare 2003;26(Suppl 1):S33-50.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
5. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin [Review]. Clin Chem 2001;47:163-63.
6. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985-92.
7. 1c in human blood. Clin Chem Lab Med 2002;40:78-89.
8. 1c values by HPLC. Clin Chem 2003;49:1412-5.
9. 1c measurement based on peptide analysis by electrospray ionization mass spectrometry with deuterium-labeled synthetic peptides as internal standards. Clin Chem 2003;49:829-31.
10. John WG. Grycated haemoglobin analysis [Review]. Ann Clin Biochem 1997;34(Pt 1):17-31.
11. Miedema K. Electrospray mass spectrometry for measurement of glycohemoglobin [Editorial]. Clin Chem 1997;43:705-7.
12. Little RR, Wiedmeyer HM, England JD, Wilke AL, Rohlfing CL, Wians FH Jr. et al. Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 1992;38:2472-8.
13. Gilbert RE, Goodall I, Young V, Jerums G. Interlaboratory variation of GHb assays in Victoria, Austraria. Diabetes Cate 1996;19:730-4.
14. Globin Gene Server. HbVar: a database of human hemoglobin variants and thalassemias. http://globin.cse.psu.edu/cgi-bin/hbvar/counter (Accessed May 2003).
15. Shackleton CHL, Witkowska HE. Mass spectrometry in the characterization of variant hemoglobins. In: Desiderio DM, ed. Mass spectrometry: clinical and biomedical applications. New York: Plenum Publishing Corp., 1994:135-99.
16. Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 2001;17:94-8.
17. Weykamp CW, Penders TJ, Muskiet FA, van der Slik W. Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods. Clin Chem 1993;39:1717-23.
18. 25(A2)Pro→Ala], an electrophoretically silent variant with impaired glycation. Clin Chem 2003;49:137-43.